Gentian Diagnostics ASA (OSL:GENT)
Norway
· Delayed Price · Currency is NOK 43.50
-0.40 (-0.91%)
Apr 28, 2026, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 672.45 million as of April 28, 2026. Its market cap has decreased by -3.11% in one year.
Market Cap
672.45M
Enterprise Value
589.51M
Revenue
176.50M
Ranking
n/a
PE Ratio
50.61
Stock Price
43.50
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 672.45M, an increase of 132.19%. That is a compound annual growth rate of 9.40%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.12B |
| Circio Holding ASA | 2.25B |
| Nordhealth AS | 1.89B |
| Photocure ASA | 1.81B |
| Nykode Therapeutics AS | 1.04B |
| ArcticZymes Technologies ASA | 1.01B |
| Vistin Pharma ASA | 1.01B |
| Omda AS | 838.76M |